Recent strides in pediatric neuropathology have revolutionized the field. The integration of advanced technologies like next-generation sequencing and methylation arrays have refined the diagnosis and classifications of pediatric brain tumors, epilepsy, and central nervous system vascular anomalies, though full clinical integration remains a challenge. Emerging technologies and genomic discoveries, particularly in the field of pediatric brain tumors, promise to further enhance diagnostic precision and patient care, underscoring the need for adaptable, forward-thinking practices.